InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Up 8.4% in April

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,943,400 shares, an increase of 8.4% from the March 31st total of 2,714,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

InnoCare Pharma Price Performance

OTCMKTS INCPF remained flat at $3.26 on Tuesday. 12,000 shares of the company traded hands, compared to its average volume of 3,450. InnoCare Pharma has a fifty-two week low of $3.26 and a fifty-two week high of $3.72. The stock’s 50 day moving average is $3.26 and its two-hundred day moving average is $3.26.

InnoCare Pharma Company Profile

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.